A hallmark of active class switch recombination: transcripts directed by I promoters on looped-out circular DNAs

Proceedings of the National Academy of Sciences of the United States of America
Kazuo KinoshitaT Honjo

Abstract

To specify when and where Ig class switch recombination (CSR) takes place, a good molecular marker closely associated with active CSR is required. CSR is accompanied by deletion of circular DNA from the Ig heavy chain locus. The circular DNA contains a DNA segment between Smu and a target S region including its I promoter, which is driven by specific cytokine stimulation before CSR. We found that the specific I promoter is still active in looped-out circular DNA and directs production of I-Cmu transcripts termed "circle transcripts." Reverse transcription-PCR demonstrated transient induction of specific circle transcripts upon CSR in a murine lymphoma cell line, CH12F3-2A, as well as spleen B cells. Production of the circle transcripts appeared to depend on expression of activation-induced cytidine deaminase (AID), an essential factor for CSR. A comparison of kinetics between circle transcripts and circular DNA showed more rapid disappearance of circle transcripts. Thus, circle transcripts may serve as a hallmark for active CSR in vitro and in vivo.

References

Jan 1, 1992·Annual Review of Immunology·L J Picker, E C Butcher
Feb 1, 1993·The Journal of Experimental Medicine·J SohnE Selsing
Feb 1, 1996·International Immunology·M NakamuraT Honjo
Mar 3, 2001·Current Opinion in Immunology·H Jacobs, L Bross
Jul 4, 2001·Nature Reviews. Molecular Cell Biology·K Kinoshita, T Honjo

❮ Previous
Next ❯

Citations

Nov 5, 2002·Immunology Letters·Rachel L RoperRichard P Phipps
Dec 17, 2008·Mucosal Immunology·J R Mora, U H von Andrian
Jun 13, 2006·Nature Immunology·Ulf KleinRiccardo Dalla-Favera
Jul 21, 2007·Nature Immunology·Mila JankovicMichel C Nussenzweig
May 17, 2008·Nature Reviews. Immunology·Andrea Cerutti
Feb 7, 2009·Proceedings of the National Academy of Sciences of the United States of America·Taichiro NonakaKazuo Kinoshita
Dec 19, 2009·Proceedings of the National Academy of Sciences of the United States of America·Maki KobayashiTasuku Honjo
Dec 4, 2002·The Journal of Experimental Medicine·Gayle C BosmaMelvin J Bosma
Jun 18, 2003·The Journal of Experimental Medicine·Bernardo Reina-San-MartinMichel C Nussenzweig
Nov 3, 2004·The Journal of Experimental Medicine·Bernardo Reina-San-MartinMichel C Nussenzweig
Jan 14, 2009·The Journal of Experimental Medicine·Siim PauklinSvend K Petersen-Mahrt
Apr 15, 2009·The Journal of Experimental Medicine·Isabelle RobertBernardo Reina-San-Martin
Apr 6, 2011·The Journal of Experimental Medicine·Sankar BhattacharyyaEdgar Serfling
Feb 9, 2010·International Immunology·Tomohiro Kurosaki
Feb 11, 2011·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Jasvir S GrewalLucille London
Apr 20, 2002·Current Opinion in Allergy and Clinical Immunology·Donata Vercelli
Feb 17, 2005·Molecular and Cellular Biology·Kefei YuMichael R Lieber
Mar 3, 2010·Annual Review of Immunology·Sidonia FagarasanKeiichiro Suzuki
Dec 26, 2002·Annual Review of Immunology·Hannah J GouldLyn Smurthwaite
Jan 26, 2005·American Journal of Respiratory Cell and Molecular Biology·Takechiyo YamadaAndrew Saxon
Sep 26, 2013·Mucosal Immunology·M LinQ Pan-Hammarström
Oct 16, 2003·Proceedings of the National Academy of Sciences of the United States of America·Tomonori EtoTasuku Honjo
Jan 26, 2005·Proceedings of the National Academy of Sciences of the United States of America·Bernardo Reina-San-MartinSimone Difilippantonio
Feb 16, 2006·Proceedings of the National Academy of Sciences of the United States of America·Taro MutoTasuku Honjo
Jan 3, 2006·Proceedings of the National Academy of Sciences of the United States of America·Laura PasqualucciRiccardo Dalla-Favera
Feb 8, 2005·Proceedings of the National Academy of Sciences of the United States of America·Keiichiro SuzukiSidonia Fagarasan
May 3, 2006·Proceedings of the National Academy of Sciences of the United States of America·Stefano CasolaKlaus Rajewsky
Feb 20, 2003·Proceedings of the National Academy of Sciences of the United States of America·Tomomitsu DoiTasuku Honjo
May 16, 2007·Médecine sciences : M/S·Claude-Agnès ReynaudJean-Claude Weill
Dec 13, 2006·Médecine sciences : M/S·Serge Jacquot, Olivier Boyer
May 26, 2004·The Journal of Cell Biology·Irene M WardJunjie Chen
Jun 21, 2011·Biochemical and Biophysical Research Communications·Mi-Ra LeePyeung-Hyeun Kim
Sep 2, 2008·Developmental and Comparative Immunology·Mick Bailey
Feb 5, 2008·Seminars in Immunology·Masayuki TsujiSidonia Fagarasan

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.